IN2014MN02060A - - Google Patents
Info
- Publication number
- IN2014MN02060A IN2014MN02060A IN2060MUN2014A IN2014MN02060A IN 2014MN02060 A IN2014MN02060 A IN 2014MN02060A IN 2060MUN2014 A IN2060MUN2014 A IN 2060MUN2014A IN 2014MN02060 A IN2014MN02060 A IN 2014MN02060A
- Authority
- IN
- India
- Prior art keywords
- amino acid
- amount
- clinical condition
- biological material
- index value
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 abstract 7
- 201000010099 disease Diseases 0.000 abstract 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 7
- 239000012620 biological material Substances 0.000 abstract 4
- 238000003745 diagnosis Methods 0.000 abstract 3
- 238000004458 analytical method Methods 0.000 abstract 2
- 238000005259 measurement Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000012284 sample analysis method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8818—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8877—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012061305 | 2012-03-18 | ||
| PCT/JP2013/001849 WO2013140785A1 (ja) | 2012-03-18 | 2013-03-18 | 疾患サンプル分析装置、分析システム及び分析方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02060A true IN2014MN02060A (cs) | 2015-08-21 |
Family
ID=49222264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2060MUN2014 IN2014MN02060A (cs) | 2012-03-18 | 2013-03-18 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20150079623A1 (cs) |
| EP (3) | EP3795997B1 (cs) |
| JP (3) | JP6037388B2 (cs) |
| CN (11) | CN110133298A (cs) |
| IN (1) | IN2014MN02060A (cs) |
| TW (2) | TWI615614B (cs) |
| WO (1) | WO2013140785A1 (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105793712B (zh) * | 2013-12-11 | 2018-01-05 | 株式会社资生堂 | 肾衰竭的早期诊断标志物 |
| HK1250785A1 (zh) * | 2015-06-10 | 2019-01-11 | Kanazawa University | 肾病的病态生物标志物 |
| CN108486028B (zh) * | 2015-10-10 | 2021-06-01 | 中国科学院南海海洋研究所 | 一种高产含有L-Val结构单元的化合物的菌株△mfnH |
| JP7123329B2 (ja) * | 2016-05-17 | 2022-08-23 | 国立大学法人大阪大学 | 腎臓病の予後予測方法及びシステム |
| WO2017200025A1 (ja) * | 2016-05-17 | 2017-11-23 | 国立大学法人大阪大学 | 糖尿病を判定するための血液試料の分析方法及びシステム |
| US20190360978A1 (en) | 2016-11-15 | 2019-11-28 | Shiseido Company, Ltd. | Multidimensional chromatographic analysis method and analysis system |
| JPWO2018159833A1 (ja) * | 2017-03-02 | 2020-01-16 | 株式会社ニコン | 細胞の判別方法、がんの検査方法、計測装置、がんの検査装置および検査プログラム |
| SG11201908102TA (en) | 2017-03-03 | 2019-10-30 | Shiseido Co Ltd | Novel compound, fluorescence derivatization reagent including said novel compound, method for optically resolving optical isomer of amino acid in which said novel compound is used, and fluorescence derivatized amino acid |
| US12220394B2 (en) | 2018-06-07 | 2025-02-11 | National University Corporation Kanazawa University | Pharmaceutical composition for prevention or treatment of kidney damage |
| WO2020045364A1 (ja) * | 2018-08-27 | 2020-03-05 | 株式会社 資生堂 | 乾癬を判定するための皮膚試料の分析方法及びシステム |
| JP6868878B2 (ja) | 2018-10-17 | 2021-05-12 | Kagami株式会社 | 糸球体濾過能力の決定方法 |
| WO2020196437A1 (ja) * | 2019-03-22 | 2020-10-01 | Kagami株式会社 | 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム |
| JP7434678B2 (ja) * | 2019-05-20 | 2024-02-21 | 花王株式会社 | 認知症又はそのリスクの検査方法 |
| EP4083628A4 (en) | 2019-12-27 | 2024-02-21 | Kagami Inc. | Method and system for estimating renal function |
| CN112180007B (zh) * | 2020-09-16 | 2023-08-18 | 上海市皮肤病医院 | 基于代谢组学的泛发性脓疱型银屑病诊断标志物及其应用 |
| CN111899883B (zh) * | 2020-09-29 | 2020-12-15 | 平安科技（深圳）有限公司 | 少样本或零样本的疾病预测设备、方法、装置及存储介质 |
| JP7600016B2 (ja) | 2021-03-30 | 2024-12-16 | 花王株式会社 | 高次脳機能の測定方法 |
| WO2023033178A1 (ja) * | 2021-09-03 | 2023-03-09 | Kagami株式会社 | 癌についての情報を提供する方法、癌についての情報を提供するシステム及び癌を治療する方法 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4290893A (en) * | 1979-05-08 | 1981-09-22 | Yeda Research & Development Co. Ltd. | Separation of amino acids by liquid chromatography using chiral eluants |
| CA2030212A1 (en) * | 1989-11-22 | 1991-05-23 | Judson V. Edwards | Peptides |
| US5374651A (en) * | 1991-09-27 | 1994-12-20 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives |
| WO1996028470A2 (en) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
| JPH0975078A (ja) * | 1995-09-13 | 1997-03-25 | Ikeda Shokken Kk | 耐熱性ｄ−アミノ酸オキシダーゼ、その製造法および微生物 |
| US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
| EP0882736A1 (en) * | 1997-06-02 | 1998-12-09 | Laboratoire Theramex S.A. | LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| JP2002517738A (ja) * | 1998-06-11 | 2002-06-18 | フォックス・チェイス・キャンサー・センター | 糖尿病患者が糖尿病に伴う病状を経験するリスクの評価方法 |
| AU775563B2 (en) * | 1999-05-14 | 2004-08-05 | Brandeis University | Nucleic acid-based detection |
| US6479063B2 (en) * | 1999-12-27 | 2002-11-12 | Kenneth Weisman | Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis |
| US7223558B2 (en) * | 2001-07-11 | 2007-05-29 | Bristol-Myers Squibb Company | Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof |
| FR2828693B1 (fr) * | 2001-08-14 | 2004-06-18 | Exonhit Therapeutics Sa | Nouvelle cible moleculaire de la neurotoxicite |
| AU2003217783A1 (en) * | 2002-02-27 | 2003-09-09 | Wake Forest University | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| FR2838444B1 (fr) * | 2002-04-10 | 2016-01-01 | Neovacs | Nouveaux peptides et leur application en therapeutique |
| US20070298041A1 (en) * | 2002-06-28 | 2007-12-27 | Tomlinson Ian M | Ligands That Enhance Endogenous Compounds |
| WO2004005935A1 (ja) * | 2002-07-04 | 2004-01-15 | Mitsubishi Pharma Corporation | 統合失調症の検査、診断方法 |
| GB0219776D0 (en) * | 2002-08-24 | 2002-10-02 | Oxford Glycosciences Uk Ltd | A protein involved in carcinoma |
| GB0223424D0 (en) * | 2002-10-09 | 2002-11-13 | Imp College Innovations Ltd | Disease-associated gene |
| JP4581994B2 (ja) * | 2002-12-09 | 2010-11-17 | 味の素株式会社 | 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体 |
| CN1761680A (zh) * | 2002-12-26 | 2006-04-19 | 武田药品工业株式会社 | 肿瘤迁移抑制素衍生物及其用途 |
| AU2003900777A0 (en) * | 2003-02-21 | 2003-03-13 | Medvet Science Pty. Ltd. | A method of diagnosis and treatment |
| EP1601948A2 (en) * | 2003-03-10 | 2005-12-07 | Sionex Corporation | Systems for differential ion mobility analysis |
| US20060217316A1 (en) * | 2003-04-02 | 2006-09-28 | Ragab El-Rashidy | Method for the treatment of prostate cancer |
| JP4291628B2 (ja) | 2003-06-12 | 2009-07-08 | 株式会社資生堂 | 液体クロマトグラフ装置及び試料に含まれる光学異性体の分析方法 |
| CN1557823A (zh) * | 2004-02-12 | 2004-12-29 | 窦德献 | L-或d-氨基酸合铂配位体、制备方法及其用途 |
| EP1756303B1 (en) * | 2004-04-09 | 2010-12-08 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Diagnostic tool for diagnosing benign versus malignant thyroid lesions |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| GB0417887D0 (en) * | 2004-08-11 | 2004-09-15 | Ares Trading Sa | Protein |
| EP1860437B1 (en) * | 2005-03-18 | 2016-09-21 | Shiseido Company, Limited | Evaluation method for skin condition utilizing squamous cell carcinoma-related antigen as measure |
| CN101189243A (zh) * | 2005-04-06 | 2008-05-28 | 阿斯利康(瑞典)有限公司 | 取代的杂环及其作为chk1、pdk1和pak抑制剂的应用 |
| JP2007077104A (ja) * | 2005-09-16 | 2007-03-29 | Shiseido Co Ltd | 血管内皮増殖因子阻害剤 |
| DK1996923T3 (da) * | 2006-03-02 | 2012-10-01 | Perkinelmer Health Sci Inc | Fremgangsmåder til adskillelse af isomerer ved hjælp af massespektrometri |
| US20070258899A1 (en) * | 2006-03-31 | 2007-11-08 | Karyon-Ctt Ltd | Diagnostic and therapeutic agents |
| JP5005955B2 (ja) * | 2006-05-24 | 2012-08-22 | 田辺三菱製薬株式会社 | 被験物質の脂質代謝異常症誘発可能性を予測する方法 |
| ATE537450T1 (de) * | 2006-06-30 | 2011-12-15 | Schering Corp | Igfbp2-biomarker |
| EP1900742A1 (en) * | 2006-09-07 | 2008-03-19 | AEterna Zentaris GmbH | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| CN101578287B (zh) * | 2006-09-06 | 2012-09-05 | 阿特纳赞塔里斯有限公司 | 地索拉唑及其衍生物与细胞结合分子的轭合物，新的地索拉唑衍生物，其制备方法及其应用 |
| US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
| KR20090111322A (ko) * | 2007-01-18 | 2009-10-26 | 세프라코 아이엔시. | 디 아미노산 옥시다제의 억제제 |
| MX2009008559A (es) * | 2007-02-12 | 2009-08-21 | Anthrogenesis Corp | Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-. |
| US8034780B2 (en) * | 2007-07-16 | 2011-10-11 | Mcphail Kerry Leigh | Isolation, purification, and structure elucidation of the antiproliferative compound coibamide A |
| CA2712309A1 (en) * | 2008-01-17 | 2009-07-23 | Toray Industries, Inc. | Composition and method for diagnosis or detection of renal cancer |
| JP2009184981A (ja) * | 2008-02-07 | 2009-08-20 | Shiseido Co Ltd | 抗ｄ−アミノ酸モノクローナル抗体及び、抗ｄ−アミノ酸モノクローナル抗体を用いたｄ−アミノ酸の免疫学的分析方法 |
| WO2009139497A1 (en) * | 2008-05-14 | 2009-11-19 | Takeda Pharmaceutical Company Limited | Cbp501 -derived agents and methods based thereon for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| WO2009143489A2 (en) * | 2008-05-22 | 2009-11-26 | Archer Pharmaceuticals, Inc. | Modulation of angiogenesis by a-beta peptide fragments |
| WO2010005982A2 (en) * | 2008-07-07 | 2010-01-14 | The General Hospital Corporation | Multiplexed biomarkers of insulin resistance |
| JP2010038796A (ja) * | 2008-08-06 | 2010-02-18 | Human Metabolome Technologies Inc | 疾患マーカー、および、疾患マーカーの測定方法 |
| EP2338988B1 (en) * | 2008-08-26 | 2015-09-16 | Kyushu University, National University Corporation | Evaluation/screening method for diseases associated with d-amino acid utilizing dao1-/- mouse |
| WO2010057647A2 (en) * | 2008-11-21 | 2010-05-27 | Universita' Degli Studi Di Milano | Methods and compositions for the diagnosis and treatment of diabetes |
| ES2799327T3 (es) * | 2009-05-05 | 2020-12-16 | Infandx Ag | Método para diagnosticar asfixia |
| CN101619092B (zh) * | 2009-08-06 | 2012-08-15 | 中国人民解放军第三军医大学第二附属医院 | 肿瘤抗原trag-3模拟表位肽及其应用 |
| US20110064828A1 (en) * | 2009-09-11 | 2011-03-17 | Novelos Therapeutics, Incorporated | Treatment of metastatic tumors and other conditions |
| JP2011247869A (ja) * | 2010-04-27 | 2011-12-08 | Kobe Univ | メタボローム解析手法を用いた特定疾患の検査方法 |
| CN102079771B (zh) * | 2010-12-10 | 2012-10-03 | 郑州大学 | 具有抗肿瘤活性的雌甾氨基酸酯化合物及其合成方法 |
-
2013
- 2013-03-18 CN CN201910585649.7A patent/CN110133298A/zh active Pending
- 2013-03-18 CN CN201710913596.8A patent/CN107449923B/zh not_active Expired - Fee Related
- 2013-03-18 IN IN2060MUN2014 patent/IN2014MN02060A/en unknown
- 2013-03-18 CN CN201910586450.6A patent/CN110133300B/zh not_active Expired - Fee Related
- 2013-03-18 US US14/385,871 patent/US20150079623A1/en not_active Abandoned
- 2013-03-18 TW TW102109586A patent/TWI615614B/zh not_active IP Right Cessation
- 2013-03-18 CN CN201910591882.6A patent/CN110161256B/zh active Active
- 2013-03-18 CN CN202210524153.0A patent/CN114966050A/zh active Pending
- 2013-03-18 JP JP2013055673A patent/JP6037388B2/ja active Active
- 2013-03-18 CN CN201910585530.XA patent/CN110133296B/zh active Active
- 2013-03-18 WO PCT/JP2013/001849 patent/WO2013140785A1/ja active Application Filing
- 2013-03-18 EP EP20207502.4A patent/EP3795997B1/en active Active
- 2013-03-18 CN CN201910591893.4A patent/CN110133301B/zh active Active
- 2013-03-18 EP EP20152640.7A patent/EP3663758A1/en not_active Withdrawn
- 2013-03-18 CN CN201910585588.4A patent/CN110133297A/zh active Pending
- 2013-03-18 CN CN201380019921.6A patent/CN104246497B/zh not_active Expired - Fee Related
- 2013-03-18 TW TW106126498A patent/TWI664425B/zh not_active IP Right Cessation
- 2013-03-18 EP EP13764636.0A patent/EP2829877B1/en active Active
- 2013-03-18 CN CN201910585495.1A patent/CN110133295A/zh active Pending
- 2013-03-18 CN CN201910586159.9A patent/CN110133299A/zh active Pending
-
2016
- 2016-10-26 JP JP2016209988A patent/JP6214016B2/ja active Active
-
2017
- 2017-09-13 JP JP2017175949A patent/JP6391787B2/ja active Active
-
2018
- 2018-09-21 US US16/137,968 patent/US20190025320A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02060A (cs) | ||
| EP2573192A4 (en) | METHOD AND KIT FOR DIAGNOSING DISEASE ASSOCIATED WITH AIM | |
| BR112015003715A8 (pt) | análise de raman, de infravermelho, ou de raman-infravermelho da estrutura de proteína de plasma de sangue periférico e sua relação para desenvolvimento cognitivo no mal de alzheimer | |
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| MX348392B (es) | Sistemas y metodos para diagnostico de la salud. | |
| WO2013040099A3 (en) | Sepsis prognosis biomarkers | |
| IN2014DN10121A (cs) | ||
| HK1215259A1 (zh) | 檢測抗苗勒管激素的同種型的抗體組合物及免疫測定方法 | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| MX342146B (es) | Sistema de monitoreo para monitorear un paciente y detectar delirio del paciente. | |
| WO2012078623A3 (en) | Biomarkers for monitoring treatment of neuropsychiatric diseases | |
| TN2015000161A1 (en) | Methylglyoxal as a marker of cancer | |
| WO2009001545A1 (ja) | 移植片対宿主疾患の検査および治療方法 | |
| JP2007289224A5 (cs) | ||
| WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
| GB201107466D0 (en) | Device and method for non-invasive collection of colorectal mucocellular layer and disease detection | |
| GB201014837D0 (en) | Biomarker signatures and uses thereof | |
| HK1207684A1 (en) | Mitochondrial toxicity test | |
| GB201102693D0 (en) | Method for identifying neonates at risk for necrotizing enterocolitis | |
| GB2515713A (en) | Methods, packaging and apparatus for collection of biological samples | |
| WO2012109258A3 (en) | Compositions adn methods for monitoring oxalate | |
| SI1990420T1 (sl) | Postopek za detekcijo in vivo aktivnosti nevrotripsina, uporaba metode in uporaba c-terminalnega 22-kda fragmenta agrina kot biomarkerja pri diagnozi in monitoringu motenj povezanih z nevrotripsinom | |
| WO2012167887A8 (en) | Diagnostic use of prosomatostatin | |
| WO2012008747A3 (ko) | 피부 진단 방법 및 키트 | |
| EA201200948A1 (ru) | Метод определения функционального состояния печени живого существа путём количественного измерения метаболизации субстратов |